Bisolvon 3 mg/ml Injektionslösung für Rinder, Schweine, Hunde und Katzen
Bisolvon 3 mg/ml Injektionslösung für Rinder, Schweine, Hunde und Katzen
Authorised
- Bromhexine hydrochloride
Product identification
Medicine name:
Bisolvon 3 mg/ml Injektionslösung für Rinder, Schweine, Hunde und Katzen
Active substance:
- Bromhexine hydrochloride
Target species:
-
Cattle
-
Dog
-
Cat
-
Pig
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Bromhexine hydrochloride3.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal3day
-
-
Dog
-
Cat
-
Pig
-
Meat and offal2day
-
-
-
Subcutaneous use
-
Dog
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QR05CB02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Labiana Life Sciences S.A.
Responsible authority:
- Austrian Agency For Health And Food Safety
Authorisation number:
- 14143
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 14/05/2024
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 14/05/2024
Labelling
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 14/05/2024
How useful was this page?: